The FY2024 (Dec) proxy of Denali Therapeutics names 23 peer companies for pay. Among Denali Therapeutics and these peers, CEO pay was 9th highest of 11 and total shareholder return was 3rd highest of 11.
9th highest of 11in Denali Therapeutics and its pay peers, FY2024 (Dec) by CEO pay:
$2.0M$33.2M
3rd highest of 11in Denali Therapeutics and its pay peers, FY2024 (Dec) by total shareholder return:
$58$443
Pay peer group, FY2024 (Dec) proxy
| CRISPR Therapeutics AG | ||
| BridgeBio Pharma | ||
| Ionis Pharmaceuticals | ||
| Intellia Therapeutics | ||
| Cytokinetics | ||
| Ultragenyx Pharmaceutical | ||
| Vir Biotechnology | ||
| Agios Pharmaceuticals | ||
| Beam Therapeutics | ||
| Sarepta Therapeutics | ||
| Alector Therapeutics | Not disclosed | Not disclosed |
| Amylyx Pharmaceuticals | Not disclosed | Not disclosed |
| Arcus Biosciences | Not disclosed | Not disclosed |
| Axsome Therapeutics | Not disclosed | Not disclosed |
| Cerevel Therapeutics Holdings | Not disclosed | Not disclosed |
| Intra-Cellular Therapies | Not disclosed | Not disclosed |
| Karuna Therapeutics | Not disclosed | Not disclosed |
| Legend Biotech Corp. | Not disclosed | Not disclosed |
| Mirati Therapeutics | Not disclosed | Not disclosed |
| Prothena Corporation | Not disclosed | Not disclosed |
| REGENXBIO | Not disclosed | Not disclosed |
| Sage Therapeutics | Not disclosed | Not disclosed |
| Vaxcyte | Not disclosed | Not disclosed |
'%20d='M450.888,318.933h6.906v.949h-2.9v7.592H453.84v-7.592h-2.953Zm15.185,3.691h-4.9v-3.691h-1.054v8.541h1.054v-3.849h4.9v3.849h1.054v-8.541h-1.054Zm5.431,1h4.745v-1H471.5v-2.689h4.956v-1h-6.01v8.594h6.221v-1H471.5Zm12.285.686,2.794,3.163h-1.318l-2.689-3.058H480.52v3.058h-1.055v-8.541h3.9a2.671,2.671,0,0,1,2.9,2.742A2.462,2.462,0,0,1,483.789,324.311Zm-.527-.79a1.727,1.727,0,0,0,1.845-1.793,1.753,1.753,0,0,0-1.845-1.793h-2.795v3.585Zm9.965-4.587,3.848,8.541h-1.16l-.843-1.9h-4.9l-.844,1.9h-1.16l3.849-8.541Zm1.476,5.694-2.057-4.588-2,4.588Zm8.647.105H500.5v2.742h-1.055v-8.541h3.9A2.9,2.9,0,1,1,503.349,324.733Zm0-4.8H500.5v3.8h2.847A1.9,1.9,0,0,0,503.349,319.936Zm6.538,3.69h4.745v-1h-4.745v-2.689h4.956v-1h-6.011v8.594h6.222v-1h-5.167Zm13.813.475a2.455,2.455,0,1,1-4.9,0v-5.115h-1.054V324.1a3.481,3.481,0,1,0,6.96,0v-5.115h-1Zm3.27-4.218h2.953v7.592h1.054v-7.592h2.9v-.949H526.97Zm9.28,7.592H537.3v-8.541H536.25Zm8.277-.844a3.2,3.2,0,0,1-3.374-3.374,3.161,3.161,0,0,1,3.374-3.427,3.393,3.393,0,0,1,2.372.949l.738-.686a4.343,4.343,0,0,0-3.11-1.265,4.227,4.227,0,0,0-4.429,4.428,4.158,4.158,0,0,0,4.429,4.377,4.465,4.465,0,0,0,3.164-1.265l-.738-.738A3.346,3.346,0,0,1,544.527,326.63Zm8.7-4.007c-1.266-.211-2.32-.474-2.32-1.423,0-1.055,1.16-1.476,2.267-1.476a2.761,2.761,0,0,1,2.32,1l.791-.474a3.344,3.344,0,0,0-3.217-1.53c-1.476,0-3.269.58-3.269,2.373,0,1.74,1.635,2.109,3.269,2.372,1.318.211,2.479.527,2.479,1.582,0,1.266-1.371,1.582-2.426,1.582a3.067,3.067,0,0,1-2.742-1.476l-.9.527a3.7,3.7,0,0,0,3.639,2c1.634,0,3.48-.633,3.48-2.531S554.914,322.887,553.227,322.623Zm-90.16-9.121h-12.18V285.611h12.18c5.062,0,9.333,2.531,9.333,7.8a6.1,6.1,0,0,1-4.114,5.747,6.942,6.942,0,0,1,5.01,6.643C473.3,311.71,468.34,313.5,463.068,313.5Zm-8.7-15.923h8.858c3.322,0,5.747-1.212,5.747-4.112,0-3.11-2.531-4.692-5.905-4.692h-8.7Zm0,12.6h8.7c2.9,0,6.749-.738,6.749-4.534-.053-3.48-3.585-4.956-6.591-4.956h-8.858Zm32.426,3.638c-6.063,0-10.334-4.007-10.334-10.281a9.833,9.833,0,0,1,10.176-10.176c6.011,0,10.6,3.691,9.807,11.547H479.729c.369,3.638,3.321,5.905,7.117,5.905,2.215,0,4.956-.9,6.222-2.479l2.215,2C493.279,312.711,489.851,313.819,486.793,313.819Zm-7.012-11.652,13.6.053c-.159-3.8-2.794-5.905-6.643-5.905A6.7,6.7,0,0,0,479.781,302.167Zm40.6,11.336h-3.163l-.052.053-.105-3.585a8.3,8.3,0,0,1-7.223,3.955c-5.642,0-10.071-3.9-10.071-10.282s4.481-10.176,10.123-10.123a8.247,8.247,0,0,1,7.276,3.9l.052-3.585h3.163Zm-10.386-16.924a7.2,7.2,0,0,0,0,14.394C519.483,310.972,519.483,296.578,509.993,296.578Zm43.34,5.694V313.45H556.6V302.219c0-5.378-3.11-8.752-8.277-8.752a7.315,7.315,0,0,0-6.908,4.271c-1.107-3.111-3.9-4.271-6.59-4.271a6.3,6.3,0,0,0-5.8,3.217l-.211-2.847H525.81L525.7,313.45h3.269V302.325c0-3.216,2.109-5.747,5.325-5.747,3.268,0,5.273,2.531,5.273,5.747V313.45h3.269V302.325c0-3.216,2.161-5.747,5.378-5.747C551.488,296.578,553.333,299.056,553.333,302.272ZM450.308,269.056a25.12,25.12,0,0,0-3.48,1.371l4.534,6.221Zm-14.5,10.6,7.012,3.27-4.587-6.169A32.115,32.115,0,0,0,435.808,279.653Zm1.423-7.54,10.809,8.911-5.273-12.917A52.977,52.977,0,0,0,437.232,272.113Zm48.93,13.6a25.049,25.049,0,0,0-1.634-3.374l-5.958,4.9ZM431.274,289.3a29.46,29.46,0,0,0-.738,3.744l7.8-.475Zm2.689-6.7a28.869,28.869,0,0,0-1.635,3.427l7.645,1.424Zm40.6-10.6-2.794,7.118,5.853-4.956A24.584,24.584,0,0,0,474.561,272.008Zm-17.135-4.323c-1.266.106-2.479.263-3.691.475l2.794,7.117ZM467.971,269l-.949,7.592,4.429-6.222A19.889,19.889,0,0,0,467.971,269Zm-37.646,27.522a30.9,30.9,0,0,0,.211,3.849l7.487-2.479Zm52.251-17.083a30.79,30.79,0,0,0-2.426-2.9l-4.481,6.222Zm-51.355,24.306a30.261,30.261,0,0,0,1.213,3.691l6.643-4.27ZM464.6,268.16c-.633-.105-1.213-.212-1.846-.264s-1.265-.105-1.845-.158l.949,7.539Zm-28.63,45.607,5.378-5.8-7.486,2.531A26.612,26.612,0,0,0,435.966,313.766Z'%20transform='translate(-430.325%20-267.685)'%20fill='%23fff'/%3e%3c/g%3e%3c/svg%3e)
23 companies
Changes by year
FY2025 (Dec) proxy
- AddedAvidity Biosciencespay peer group
- AddedBiohavenpay peer group
- AddedBlueprint Medicinespay peer group
- AddedDyne Therapeuticspay peer group
- AddedIovance Biotherapeuticspay peer group
- AddedNeumora Therapeuticspay peer group
- AddedRevolution Medicinespay peer group
- RemovedAmylyx Pharmaceuticalspay peer groupAs a result of the determination of the 2025 peer group based on the revised criteria, seven companies that had been included in the 2024 peer group were removed as they no longer met the criteria listed above: Amylyx Pharmaceuticals, Cerevel Therapeutics, Ionis Pharmaceuticals, Karuna Therapeutics, Legend Biotech, Mirati Therapeutics
- RemovedCerevel Therapeuticspay peer groupAs a result of the determination of the 2025 peer group based on the revised criteria, seven companies that had been included in the 2024 peer group were removed as they no longer met the criteria listed above: Amylyx Pharmaceuticals, Cerevel Therapeutics, Ionis Pharmaceuticals, Karuna Therapeutics, Legend Biotech, Mirati Therapeutics
- RemovedIonis Pharmaceuticalspay peer groupAs a result of the determination of the 2025 peer group based on the revised criteria, seven companies that had been included in the 2024 peer group were removed as they no longer met the criteria listed above: Amylyx Pharmaceuticals, Cerevel Therapeutics, Ionis Pharmaceuticals, Karuna Therapeutics, Legend Biotech, Mirati Therapeutics
- RemovedKaruna Therapeuticspay peer groupAs a result of the determination of the 2025 peer group based on the revised criteria, seven companies that had been included in the 2024 peer group were removed as they no longer met the criteria listed above: Amylyx Pharmaceuticals, Cerevel Therapeutics, Ionis Pharmaceuticals, Karuna Therapeutics, Legend Biotech, Mirati Therapeutics
- RemovedLegend Biotechpay peer groupAs a result of the determination of the 2025 peer group based on the revised criteria, seven companies that had been included in the 2024 peer group were removed as they no longer met the criteria listed above: Amylyx Pharmaceuticals, Cerevel Therapeutics, Ionis Pharmaceuticals, Karuna Therapeutics, Legend Biotech, Mirati Therapeutics
- RemovedMirati Therapeuticspay peer groupAs a result of the determination of the 2025 peer group based on the revised criteria, seven companies that had been included in the 2024 peer group were removed as they no longer met the criteria listed above: Amylyx Pharmaceuticals, Cerevel Therapeutics, Ionis Pharmaceuticals, Karuna Therapeutics, Legend Biotech, Mirati Therapeutics
- RemovedSarepta Therapeuticspay peer groupAs a result of the determination of the 2025 peer group based on the revised criteria, seven companies that had been included in the 2024 peer group were removed as they no longer met the criteria listed above: Amylyx Pharmaceuticals, Cerevel Therapeutics, Ionis Pharmaceuticals, Karuna Therapeutics, Legend Biotech, Mirati Therapeutics
FY2024 (Dec) proxy
- AddedAmylyx Pharmaceuticalspay peer group
- AddedAxsome Therapeuticspay peer group
- AddedBridgeBio Pharmapay peer group
- AddedIntra-Cellular Therapiespay peer group
- AddedProthena Corporationpay peer group
- AddedVaxcytepay peer group
- RemovedAllogene Therapeuticspay peer groupAs a result of the determination of the 2024 peer group based on the revised criteria, thirteen companies that had been included in the 2023 peer group were removed as they no longer met the criteria listed above: Allogene Therapeutics, Arvinas, Fate Therapeutics, Global Blood Therapeutics, NGM Biopharmaceuticals, Reata Pharmaceuticals
- RemovedArvinaspay peer groupAs a result of the determination of the 2024 peer group based on the revised criteria, thirteen companies that had been included in the 2023 peer group were removed as they no longer met the criteria listed above: Allogene Therapeutics, Arvinas, Fate Therapeutics, Global Blood Therapeutics, NGM Biopharmaceuticals, Reata Pharmaceuticals
- RemovedFate Therapeuticspay peer groupAs a result of the determination of the 2024 peer group based on the revised criteria, thirteen companies that had been included in the 2023 peer group were removed as they no longer met the criteria listed above: Allogene Therapeutics, Arvinas, Fate Therapeutics, Global Blood Therapeutics, NGM Biopharmaceuticals, Reata Pharmaceuticals
- RemovedGlobal Blood Therapeuticspay peer groupAs a result of the determination of the 2024 peer group based on the revised criteria, thirteen companies that had been included in the 2023 peer group were removed as they no longer met the criteria listed above: Allogene Therapeutics, Arvinas, Fate Therapeutics, Global Blood Therapeutics, NGM Biopharmaceuticals, Reata Pharmaceuticals
- RemovedNGM Biopharmaceuticalspay peer groupAs a result of the determination of the 2024 peer group based on the revised criteria, thirteen companies that had been included in the 2023 peer group were removed as they no longer met the criteria listed above: Allogene Therapeutics, Arvinas, Fate Therapeutics, Global Blood Therapeutics, NGM Biopharmaceuticals, Reata Pharmaceuticals
- RemovedReata Pharmaceuticalspay peer groupAs a result of the determination of the 2024 peer group based on the revised criteria, thirteen companies that had been included in the 2023 peer group were removed as they no longer met the criteria listed above: Allogene Therapeutics, Arvinas, Fate Therapeutics, Global Blood Therapeutics, NGM Biopharmaceuticals, Reata Pharmaceuticals
- RemovedVerve Therapeuticspay peer groupAs a result of the determination of the 2024 peer group based on the revised criteria, thirteen companies that had been included in the 2023 peer group were removed as they no longer met the criteria listed above: Allogene Therapeutics, Arvinas, Fate Therapeutics, Global Blood Therapeutics, NGM Biopharmaceuticals, Reata Pharmaceuticals
FY2023 (Dec) proxy
- AddedBeam Therapeuticspay peer group
- AddedCerevel Therapeuticspay peer group
- AddedCytokineticspay peer group
- AddedIntellia Therapeuticspay peer group
- AddedKaruna Therapeuticspay peer group
- AddedLegend Biotechpay peer group
- AddedVerve Therapeuticspay peer group
- RemovedAllakospay peer groupAs a result of the determination of the 2023 peer group based on the revised criteria, seven companies that had been included in the 2022 peer group were removed as they no longer met the criteria listed above: Allakos, Atara Biotherapeutics, Biohaven Pharmaceutical, Editas Medicine, Sangamo Therapeutics
- RemovedAtara Biotherapeuticspay peer groupAs a result of the determination of the 2023 peer group based on the revised criteria, seven companies that had been included in the 2022 peer group were removed as they no longer met the criteria listed above: Allakos, Atara Biotherapeutics, Biohaven Pharmaceutical, Editas Medicine, Sangamo Therapeutics
- RemovedBiohaven Pharmaceuticalpay peer groupAs a result of the determination of the 2023 peer group based on the revised criteria, seven companies that had been included in the 2022 peer group were removed as they no longer met the criteria listed above: Allakos, Atara Biotherapeutics, Biohaven Pharmaceutical, Editas Medicine, Sangamo Therapeutics
- RemovedEditas Medicinepay peer groupAs a result of the determination of the 2023 peer group based on the revised criteria, seven companies that had been included in the 2022 peer group were removed as they no longer met the criteria listed above: Allakos, Atara Biotherapeutics, Biohaven Pharmaceutical, Editas Medicine, Sangamo Therapeutics
- RemovedSangamo Therapeuticspay peer groupAs a result of the determination of the 2023 peer group based on the revised criteria, seven companies that had been included in the 2022 peer group were removed as they no longer met the criteria listed above: Allakos, Atara Biotherapeutics, Biohaven Pharmaceutical, Editas Medicine, Sangamo Therapeutics
- RemovedZogenixpay peer groupAs a result of the determination of the 2023 peer group based on the revised criteria, seven companies that had been included in the 2022 peer group were removed as they no longer met the criteria listed above: Allakos, Atara Biotherapeutics, Biohaven Pharmaceutical, Editas Medicine, Sangamo Therapeutics
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.